About Pharma Technology Focus Magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format. Produced by a team of experienced editors and contributors, this monthly magazine brings together the latest insights and innovations from across the industry, including new discoveries, R&D and clinical trials, manufacturing technologies and supply chain management, as well as insiders’ views and in-depth analysis of the latest market and investment trends and regulatory changes affecting the industry.
August 2019 Top
In this issue: breakthroughs in HIV treatment, understanding drug-resistant TB, the fallout from Teva’s price fixing scandal, tackling unlicensed stem cell clinics, and much more.
July 2019 Top
In this issue: Exploring the potential of the underwater biome in drug development, nationalised drug discovery in the UK, predicting drug failures with AI, and much more.
June 2019 Top
In this issue: A look back at Scott Gottlieb’s time as FDA commissioner, connecting drugmakers with material suppliers, the pharmaceutical properties of CBD, and much more.
May 2019 Top
In this issue:The buzz around esketamine, innovative treatments targeting memory loss, driving an open-science approach to drug development, the state of cannabis in the UK and much more.
April 2019 Top
In this issue: Addressing the issue of snake bites and antivenom, the medicinal potential of illegal drugs, tackling rogue online pharmacies, and much more.
March 2019 Top
In this issue: The disappearing supply of pink Migraleve in the UK, drug ingredients sourced from corn, using machine learning to accelerate diagnosis and treatment of rare diseases, and much more.
February 2019 Top
In this issue: Knock on effects of the Valsartan recall, the future of AI in healthcare, the history of the Petri dish, and much more.
January 2019 Top
In this issue: A new class of cancer combo treatments, antidepressants in the environment, microbiome-based drug development, and more.
December 2018 Top
In this issue: China’s growing pharmaceutical market, antimicrobial resistance, the rise of tech giants in healthcare, and more.
November 2018 Top
In this issue: HPV vaccine programmes, dominantly inherited Alzheimer’s disease, a unique brain ‘fingerprint’ and more.
Special Issue Top
In this issue: Manufacturing personalised medicine, the economics of CAR-T treatments, AI in drug combination therapy and more.
October 2018 Top
In this issue: Making manufacturing work in gene and cell therapies, AI generated compounds, clinical trial transparency in the Americas, and more.
September 2018 Top
In this issue: Boosting trust in big pharma, the highs and lows of the world’s most expensive drug, gene therapy, and more.
August 2018 Top
In this issue: Major investment signals confidence in the search for new products developed from DNA found in soil, a medical milestone for cannabinoids in the US, streamlining clinical research, and more.
July 2018 Top
In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and more.
June 2018 Top
In this issue: A surge of M&A activity in the biotech space, the history of drug development for mumps, a profile of the Swiss pharmaceutical market, using digital tech to unlock billions in savings for pharma companies, and more.
May 2018 Top
In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre for Drug Research and Development, and more.
April 2018 Top
In this issue: The world’s pharma manufacturing hotspots, creating a universal flu vaccine, obstacles to improving the treatment of Alzheimer’s disease, the potential of growth drugs, detecting racemisation in drugs, and more.
March 2018 Top
In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells, a look at drug pricing policies around the world, and more.
February 2018 Top
In this issue: How cancer drug resistance works, accessing funding for rare diseases, India’s attempt to redefine over the counter drugs, the biotech potential of slipper limpets, Dundee University’s influence in pharma research, and more.
January 2018 Top
In this issue: Breaking cancer’s drug addiction, the NHS’ decision to switch from biologics to biosimilars, Elsevier’s common model for data sharing, a generic antiretroviral for HIV/AIDS, the opioid addiction crisis in the US, and more.
Yearbook 2017 Top
In this issue: We round up the biggest pharma developments and stories from around the globe in 2017, consider the impact Brexit could have on IDMP preparations, take a closer look at the outlook for the pharmaceutical industry in 2018, and more.
December 2017 Top
In this issue: Calls for closer ties between the NHS and pharma, Norway’s unique prescription database, a new way to reduce the risk of heart attacks, MDMA’s potential to treat PTSD, a curative compound derived from red sage, and more.
November 2017 Top
In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X’s work on antibacterial R&D, helping nanomedicines reach their target, radioactive isotopes battling cancer, and more.
October 2017 Top
In this issue: UK pharma industry takes NICE to court over price caps, Amazon’s potential to enter the US pharmacy industry, a new platform to capture molecules from fungi, the current state of drug development in osteoporosis, and more.
September 2017 Top
In this issue: A new tool to encourage links between industry and academia, blockchain’s applications for pharma, using Zika to attack brain tumour cells, treating MS with nanotechnology, the benefits of publicly funded cancer trials, and more.
August 2017 Top
In this issue: The UK’s healthcare spending problem, PhRMA’s new R&D spending requirements, undermining supply chain security by importing foreign drugs, milestone cystic fibrosis trials, a personalised treatment approach for panic disorder, and more.
July 2017 Top
In this issue: Solving US drug pricing issues by importing cheaper Canadian drugs, underexplored fields in immuno-oncology, a new temperature-resistant rabies and yellow fever vaccine, the increasingly popularity of adaptive clinical trials, and more.
June 2017 Top
In this issue: Challenging the link between innovation and US drug pricing, the impact of Brexit on life sciences companies, a new study on the effects of cognitive-enhancing drugs, using crowdfunding to unlock cancer therapies, and more.
May 2017 Top
In this issue: Promising Alzheimer’s drugs in development, potential applications for the hormone kisspeptin, the cost of failed drug candidates, a new app matching patients to clinical trials, pharma packaging trends, and more.
April 2017 Top
In this issue: Japan’s pharma industry looks abroad, Trump’s plans for US drug manufacturing, unlocking regenerative medicine, the medical benefits of turmeric, the dangers posed by first-in-human drug trials, and more.
March 2017 Top
In this issue: Clinical research in the UK, fighting diabetes with peptides, balancing speed and safety when reviewing new drugs, the potential of shark antibodies to treat Alzheimer’s, Elsevier’s new project to boost innovation, and more.
February 2017 Top
In this issue: India’s new drug pricing policy, bringing transparency to pharma industry payments, a UK innovation centre enabling new means of drug discovery, how artificial intelligence is being used in drug development, and more.
January 2017 Top
In this issue: Senator Bernie Sanders continues to rail against the pharma industry, why companies pay to prolong patents, a new genomic array helping fight disease in Africa, treating mononucleosis, a new era for ibuprofen, and more.
December 2016 Top
In this issue: Pfizer’s acquisition of AstraZeneca’s antibiotics unit, new ideas to tackle antimicrobial resistance, vaccines to look out for in 2017, targeting Tourette syndrome, using ketamine to treat depression, and more.
November 2016 Top
In this issue:A report calls for Oxford and Cambridge to work together in the biopharma sector, IBM’s new lab-on-a-chip technology, whether harnessing telomerase could trick the ageing process, how BERG is using AI to develop drugs, and more.
October 2016 Top
In this issue:Efficiency in Australia’s pharma industry, India’s move to biosimilars, painkillers that don’t rely on opioids, NHS England’s funding of HIV drug PrEP, whether stem cell transplants can be used to treat MS, and more.
September 2016 Top
In this issue: Maximising investment by cancer megafunds, positive clinical trials for an antibody to treat lupus, how copper can be used to tackle obesity, whether day and night should influence our drug regimes, a device to soak up excess drugs and more.
August 2016 Top
In this issue: Improving treatment for refugees, making global drug price regulation work, a new approach to AMR, tackling depression with psilocybin, combating counterfeit Viagra, innovations in temperature controlled packaging and more.
July 2016 Top
In this issue: Nurturing an African pharma boom, the challenges of designing biodegradable drugs, the UK’s R&D tax credit scheme, advances in prostate cancer treatment, treating heroin addiction, best practice for anonymising clinical trial data and more.
June 2016 Top
In this issue: The breast cancer drug pipeline, getting biosimilars to market, the debate about animal research, olive leaf extract on trial, text mining in the biotech sector, outsourcing clinical trials in emerging markets and more.
May 2016 Top
In this issue: Getting a grip on the Zika virus, mining for medicines, Obama’s cancer moonshot, learning from Bial’s French trial disaster, digital innovation in pharmaceutical packaging and more.
April 2016 Top
In this issue:Israel’s pharma market, what Brexit would mean for clinical research in the UK, developments in obstetrics, the trouble with inhalable insulin, the FDA’s new support for innovation in manufacturing, plant-based vaccine manufacturing and more.
March 2016 Top
In this issue: Clinical trials in Russia, how understanding the microbiome could help with drug delivery, making the most of data analytics, the potential of wearable trackers in clinical trial data collection, the pharma industry’s role in fighting climate change and more.
February 2016 Top
In this issue: A look inside China’s pharmaceutical market, GSK’s pipeline to 2020, tackling the world’s most pressing clinical needs, new digital tools for clinical trials, a new approach to predicting side effects and more.
January 2016 Top
In this issue: Bridging the GP – big pharma divide, the year ahead in regulation, world-changing research into parasitic diseases, the first 3D printing method for adult stem cells, the ethics of marketing pharmaceuticals online, and more.
December 2015 Top
In this issue: regulation updates for EU-FMD and IDMP, why flibanserin remains controversial, why farm dust could be the key to preventing asthma, new efforts to reduce placebo use in clinical trials, and more.
November 2015 Top
In this issue: The industry’s quest for abuse-deterrent painkillers, progress of the US Drug Quality and Security Act, innovations in asthma treatment, the search for alternatives to antibiotics, how the UK’s biosciences sector can attract new talent, and more.
October 2015 Top
In this issue: How the industry can prepare for Britain’s EU referendum, London’s proposed £10bn drug development ‘megafund’, why antibiotics innovation has stalled despite the growing AMR threat, new malaria research that could lead to a $1 cure, the potential of statins for cancer treatment, and more.
September 2015 Top
In this issue: South Africa’s long road to domestic manufacturing, the 21st Century Cures Act divides opinion in the US, closing the talent gap in contract research, the growing market for unlicensed drugs, and more.
August 2015 Top
In this issue: New findings on fake medicines, progress in predicting cancer, the rocky road ahead for biosimilars developers, a new wave of treatments for hearing loss, trends in packaging and more.
July 2015 Top
In this issue: A new gene therapy for lung cancer, a new approach to hepatitis B vaccines, tackling obesity with bioengineered bacteria, what Apple’s ResearchKit brings to clinical trials, big data solutions to pharma’s problems, European marketing self-regulation under fire, and more.
May 2015 Top
In this issue: How pharmacogenomics is paving the way for personalised drug plans, new ideas for flu vaccine development, fighting antimicrobial resistance on all fronts, why a regulatory re-think is needed to unlock the potential of regenerative medicine and more.
March 2015 Top
In this issue: Unlocking unknown benefits of existing drugs, a new approach to stopping cancer spread, competition and opportunities in the HIV drugs market, building up business in Japan, striking the right balance with child-resistant drug packaging and more.
January 2015 Top
In this issue: Building on the success of dropping child cancer death rates in the UK, upcoming changes for 2015, the effects of mergers on innovation, rethinking the role of the placebo, neuropathic pain treatments in the pipeline, and more
December 2014 Top
In this issue: New combinations of existing cancer treatments show promising results, complying with new EU-FMD safety features, increasing time to market with new technologies, lymphoma treatments in the pipeline, tackling AMR with nanotechnology and more.
October 2014 Top
The clinical trials special issue: the economics of large-scale trials, new treatments for Type 2 Diabetes and obesity, the benefits of adaptive licensing for orphan drugs, data and trial management software and more.
August 2014 Top
In this issue: A new approach to Alzheimer’s clinical trials, India’s ambitions to jump from generics manufacturer to drug innovator, integrating real-life data into drug development, a new era for PAH treatment in the UK, self-expiring pharma packaging and more.
June 2014 Top
In this issue: Ireland’s pharma market after the patent cliff, changes in life science investment, the drug pricing debate, statins in the spotlight, the medical potential of honey and more
April 2014 Top
In this issue: A functional cure for HIV, the new clinical data sharing principles, what the industry has learned from the influenza A pandemic five years ago, pain-free injections with microneedles and more
February 2014 Top
In this issue: Boosting clinical trial participation, the potential of bioprinting in regenerative medicine, progress in type 1 diabetes vaccines, the US military’s plant-based vaccine production project, software that speeds up tumour tissue analysis, controlling malaria and dengue fever outbreaks with open-source modelling, and more.
December 2013 Top
In this issue: The future of bioelectronic medicine, the winners of the Pharma Technology Focus Awards 2013, what the US Supreme Court’s ruling on DNA patenting means for future research, the ethics of advertising prescription drugs directly to patients, why elemental impurity analysis needs to be modernised, a look at the influenza vaccine market, the controversial decision-making process for cancer drug approvals in the UK, and more
October 2013 Top
In this issue: How personalised medicine could revolutionise future medical care, recent breakthroughs in the battle against Malaria, how changes to GMP guidelines across Europe will affect CMOs and their customers, overcoming the challenges of managing cold chains in regions with weak infrastructures, a look at new anti-counterfeit regulations for manufacturing and distribution, and more
August 2013 Top
In this issue: Could nano-robots change the game for targeted drug delivery? Plus: The cancer-killing avian virus, challenges in implementing the EC’s Falsified Medicines Directive, Type 2 diabetes market insight, the placebo trend in the UK, the health implications of antibiotics in the food chain, new developments in drug delivery devices, and more
June 2013 Top
In this issue: New opportunities for the generics market, the potential of plant molecular farming, a new generation of transdermal patches, how a new nerve targeting drug delivery system could revolutionise the treatment of intractable pain, the challenges of developing combination drugs, cold chain technology, and more
April 2013 Top
In this issue: The EU’s parallel drug trade dilemma, the controversy surrounding clinical data disclosure, a new subcutaneous drug delivery platform, the future of analgesic drug development, building an effective cold chain, Mexico’s rise in the pharma market, growth opportunities for biopharma in Latin America, and more
March 2013 Top
In this issue: New hope for preventative HIV vaccination, crowdfunding clinical research, effective cancer treatment with antibody-drug conjugates, the role of naïve t-cells in cancer and HIV treatment, continuous manufacturing, new inhalation technology, and more.
In Short Supply: The role of the supply chain in tackling drug shortages | Plus: Getting emergency healthcare into Syria, cloud-based supply chain management, preventing medical cargo theft, the push for continuous temperature monitoring, and more
Small Players, Big Potential: Why small biotech companies take the innovative edge in new drug development | Plus: A push for Alzheimer’s research, the search for a more effective TB treatment, new schizophrenia discoveries, and more
Fighting Fakes: From packaging technology to new legislation, industry and regulators are battling on all fronts against the spread of counterfeit medicines.
Output vs. Quality: Are increasingly stringent regulations on manufacturing and ingredients the cause for the growing problem of drug shortages?
Cutting the Paper Trail: Clinical trials need better streamlined technology and industry-wide standards to become more efficient
Programmable, self-propelled and powerful: How nano-devices could open up the door to a new era of highly targeted drug delivery.
Clouds of change : How advanced computing technology will help Big Pharma to manage and streamline the growing amounts of ever more complex clinical data.
In the pipeline: From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new frontiers.
In this issue: Essential protection – pharmaceuticals place high demands on packaging, giving rise to ever more advanced packaging technologies to ensure the safety and usability of medicines.
Issue theme: Manufacturing and ingredients – We look at technological advances in the field of pharmaceutical manufacturing and APIs and explore some of the challenges faced by companies operating in the sector.
Issue theme: Trial & Success – We explore the best strategies and the latest technology that can hep to make clinical trials quicker, safer and more cost-efficient
Issue theme: Advanced Delivery – From nanoscale targeting to controlled release breakthroughs, rapidly evolving delivery methods are making medicines more effective than ever
Issue Theme: Essential Networks – How the industry can secure supply chains while improving efficiencies in logistics
Issue Theme: Finding new cures – Market shifts and emerging technologies are pushing drug development into a new era
Issue Theme: What’s on the label – Advanced packaging and labelling systems are essential in making medicines safer
Issue Theme: Life-saving precision: We look at trends in pharmaceutical manufacturing
Issue Theme: Combating counterfeits – how the industry can protect products, the supply chain and patients from the black market trade
Issue Theme: Better medicine – from needle free to nanotechnology, new drug delivery systems are set to revolutionise medical treatment
Issue Theme: The road to market – how pharma companies can meet the challenges of today’s increasingly complex supply chains
Whether you want to increase brand awareness, deliver a complex message or launch a new product, our online magazine provides a creative medium to communicate effectively with your audience.
Reach your audience – delivered directly to 50,000 industry professionals inboxes and be seen by our online community of 45,000 visitors every month.
Rich digital content – enables you to provide innovative content and features to engage your reader more with your brand.
Editorial focused advertorial content – giving you the opportunity to communicate a more detailed message.
Direct response – embedded links in adverts enable you to measure responses and generate new leads through a high profile advertising medium.
We offer one of the most varied and competitive price plans available today. Select from an array of creative and flexible solutions across a range of media to meet your specific needs.
Full Page Advertisements
A full page advertisement that fills the screen of all readers of the online magazine is a fantastic way to improve customer loyalty and build a stronger brand with strong visual images, text and embedded links.
Furthermore, you can enhance this advertisement with both animation and video, to further excite and engage our readership.
Our online magazines also offer the unique opportunity for you to utilise the most effective mechanism for delivering dynamic, creative and in-depth content. Our advertorial content opportunities offer you to chance to work directly with our editorial team to create the perfect combination of company or product overview and brand promotion delivered to our users in the power-technology.com house style they know and trust.
“We at Bürkert chose to work with Pharma Technology Focus online magazine because we find it to be a very innovative tool, not only as regards the stunning design but also elements such as interesting animations, videos and interactive images.
We also appreciate the monthly in-depth focus on a particular pharmaceutical industry area. Last but not least, working with the people from Pharma Technology Focus has always been great as we have found them to be very patient, accommodating and friendly, even when we were a little late with submitting our materials. Altogether, we consider PTF an excellent tool for promoting our brand within the pharmaceutical industry.” Bürkert